| Old Articles: <Older 49091-49100 Newer> |
|---|
 |
The Motley Fool
June 3, 2011
Brian Orelli |
Tag-Teaming Melanoma for Fun and Profit Bristol-Myers Squibb and Roche hook up.   |
The Motley Fool
June 3, 2011
Chris Baines |
How SodaStream Goes to $160 You should worry about SodaStream's business, but not about its valuation. |
The Motley Fool
June 3, 2011
Rich Smith |
GE Takes a Fast Boat to China New FlexEfficiency generator notches two quick sales. |
The Motley Fool
June 3, 2011
Aimee Duffy |
This Brand Is Poised for Greatness Under Armour, an athletic apparel company has its sights set on No. 1. |
The Motley Fool
June 3, 2011
Alex Dumortier |
Banks Blindsided by a Housing Double-Dip For the top banks, the hits just keep on coming. |
The Motley Fool
June 3, 2011
Sean Williams |
Stop Being Frightened by Freight Despite popular belief, oil prices, which have been hovering around $100 per barrel for the better part of three months now, have not completely sucked the life force out of the freight sector. |
The Motley Fool
June 3, 2011
Matt Koppenheffer |
5 Stocks That Need to Be on Your Watchlist I've honed in on the holdings of six top value investors and found five stocks that they've been snapping up. |
The Motley Fool
June 3, 2011
Katie Spence |
Get In Before This Stock Goes Global Burritos are taking over the world. Should Chipotle take over your portfolio? |
The Motley Fool
June 3, 2011
John Rosevear |
Ford's Very Weird Month Why May's auto sales weren't evidence of anything except weirdness. |
The Motley Fool
June 3, 2011
Luke Timmerman |
Orexigen, Facing High Hurdle at FDA, Puts Obesity Drug Development on Hold The close attention paid to safety makes this drug difficult to get right. |
| <Older 49091-49100 Newer> Return to current articles. |
